This week in cardiology from heartwire

View all posts »

#175: Apixaban approved: Now, which anticoagulant to use?; darbepoetin alfa disappoints in RED-HF; suspect thrombus with signs of early valve degeneration after TAVI; half of cardiology practices now integrated with hospitals

Jan 25, 2013 11:20 EST


For the week ending January 25, 2013 we discuss the following top cardiology news from heartwire:

 

And also, in brief:

 

Join us for a comprehensive review of this week's most important cardiology news.





« Previous Post
#176: No benefit to dual RAS blockade in meta-analysis; metabolic syndrome in 40s linked to TV, lack of exercise, at age 16; Canadian Riata experience: Electrical failures eclipse externalized cables; "napkin-ring sign" on CT identifies high-risk coronary
Feb 1, 2013 10:45 EST Next post »
#174: Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury
Jan 18, 2013 14:50 EST




You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access